SCHEMBL13508199

SCHEMBL13508199

Cc1ccc(N(c2ccccc2)c2ccc3c(c2)oc2c4oc5cc(N(c6ccccc6)c6ccc(C)cc6)ccc5c4c4ccccc4c32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.40
MAOB P27338 3/20 0.35
ALDH1A1 P00352 6/20 0.34
HPGD P15428 4/20 0.34
IGLV6-57 P01721 4/20 0.34
CYP3A4 P08684 4/20 0.34
MAPK1 P28482 3/20 0.34
CASP7 P55210 3/20 0.34
HSD17B10 Q99714 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
CASP1 P29466 2/20 0.34
ATM Q13315 2/20 0.34
GLA P06280 2/20 0.34
HIF1A Q16665 2/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
HTT P42858 2/20 0.34
ESR1 P03372 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507931 0.97 MAOB (0.37) TDP1MAOBALDH1A1HPGDIGLV6-57
SCHEMBL13508052 0.93 ALDH1A1 (0.37) TDP1ALDH1A1HPGDIGLV6-57CYP3A4
SCHEMBL17658554 0.92 TDP1 (0.37) TDP1MAOBALDH1A1HPGDIGLV6-57
SCHEMBL18267103 0.92 TDP1 (0.38) TDP1MAOBALDH1A1HPGDIGLV6-57
SCHEMBL13508069 0.92 TDP1 (0.36) TDP1ALDH1A1HPGDIGLV6-57CYP3A4
SCHEMBL13508073 0.92 TDP1 (0.38) TDP1ALDH1A1HPGDIGLV6-57CYP3A4
SCHEMBL16153186 0.91 TDP1 (0.38) TDP1MAOBALDH1A1HPGDIGLV6-57
SCHEMBL18905009 0.89 ALDH1A1 (0.35) TDP1MAOBALDH1A1HPGDIGLV6-57
SCHEMBL13507081 0.88 TDP1 (0.41) TDP1MAOBALDH1A1HPGDIGLV6-57
SCHEMBL13508110 0.87 TDP1 (0.34) TDP1MAOBALDH1A1HPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
EP-2145936-A2 Fluorene and pyrene derivatives and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 TDP1 2842/4885MAOB 446/4885ALDH1A1 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.